key: cord-0826700-ieceygur
authors: Samanta, Palas; Ghosh, Apurba Ratan
title: Environmental perspectives of COVID-19 outbreaks: A review
date: 2021-09-21
journal: World J Gastroenterol
DOI: 10.3748/wjg.v27.i35.5822
sha: 660c384561c95784903e6ee3b83eb4d1af010196
doc_id: 826700
cord_uid: ieceygur

The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began in December 2019 in China and has led to a global public health emergency. Previously, it was known as 2019-nCoV and caused disease mainly through respiratory pathways. The COVID-19 outbreak is ranked third globally as the most highly pathogenic disease of the twenty-first century, after the outbreak of SARS-CoV and Middle East respiratory syndrome in 2002 and 2012, respectively. Clinical, laboratory, and diagnostic methodology have been demonstrated in some observational studies. No systematic reviews on COVID-19 have been published regarding the integration of COVID-19 outbreaks (monitoring, fate and treatment) with environmental and human health perspectives. Accordingly, this review systematically addresses environmental aspects of COVID-19 outbreak such as the origin of SARS-CoV-2, epidemiological characteristics, diagnostic methodology, treatment options and technological advancement for the prevention of COVID-19 outbreaks. Finally, we integrate COVID-19 outbreaks (monitoring, fate and treatment) with environmental and human health perspectives. We believe that this review will help to understand the SARS-CoV-2 outbreak as a multipurpose document, not only for the scientific community but also for global citizens. Countries should adopt emergency preparedness such as prepare human resources, infrastructure and facilities to treat severe COVID-19 as the virus spreads rapidly globally.

A series of patients with unidentified pneumonia, caused by β-coronavirus, was reported in late December 2019 in Wuhan (Hubei Province), China. Coronavirus disease 2019 (COVID- 19) outbreaks are clinically very similar to viral pneumonia. A number of experts from the PRC Centers for Disease Control declared that this respiratory disorder (alternatively known as novel coronavirus pneumonia, NCP) was caused by a novel coronavirus [1] . The World Health Organization (WHO) initially named the disease as 2019-nCoV (2019-novel coronavirus) on January 12, 2020. It was officially later named COVID-19 on February 11, 2020 by the WHO. On the same date, the International Committee on Taxonomy of Viruses named the virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after developing the genome sequence from a COVID-19 patient in Wuhan on January 7, 2020. The virus belongs to the β-coronavirus family, which is very prevalent in nature among other families. Similar to other viruses, the SARS-CoV-2 also has many natural hosts including different intermediate and final hosts, which makes it challenging for scientific communities to treat and prevent COVID-19 outbreaks. It has higher transmission and infection potential but causes a lower mortality rate compared with SARS-CoV and Middle East respiratory syndrome (MERS-CoV) [2] . The genomic sequence of SARS-CoV-2 revealed that it has 79.5% and 96% similarity with SARS-CoV and bat coronavirus, respectively [1] , which implies that bats might be the source of SARS-CoV-2. Although the COVID-19 outbreak started in China, the virus has spread to over 213 countries with the highest rate of infection in the United States, Italy, France, and Spain among others as per data published by the WHO on December 13, 2020 ( Figure 1 ). There are approximately 202608306 confirmed SARS-CoV-2 cases and 4293591 deaths worldwide. Consequently, COVID-19 has emerged as a global threat to public health and is steadily growing due to human-to-human transmission. Moreover, this transmission also spreads in different environmental sectors such as water, air, soil, sewage and fecal matter [3] . Additionally, this process is accelerated by a number of meteorological factors namely temperature, weather, humidity and air quality parameters including particulate matter, SOx, NOx and carbon, etc. Therefore, a better understanding of the global consequences of COVID-19 is required with regard to environmental perspectives. Accordingly, this review will address the origin of SARS-CoV-2, route of transmission, pathogenesis, epidemiological characteristics, diagnostic methodology, treatment options and technological advancement for the prevention of COVID-19 outbreaks with regard to environmental perspectives in order to acquire the latest understanding of this new infectious disease of which certain immediate as well as long-term remedial measures can be explored.

SARS-CoV-2 is a β-coronavirus and is enveloped with non-segmented Orthocoronavirinae subfamily RNA [4] . Among the four genera, γ-and δ-CoV infect birds while α-and β-CoV infect mammals including humans ( Table 1 ). The α-and β-CoV have six

The animal-human interface is not a new concept. Zoonotic diseases with a wildlife reservoir have long been recognized as significant public health problems. Indeed, up to three-quarters of infectious diseases that cause human infections are known to be zoonotic [11] . Apart from this, the complexity of animal, human, and environmental factors is thought to play a critical role in its emergence [12] . On the other hand, contact with infected patients and droplets are considered to be major transmission routes of COVID-19. Aerosol transmission is another important route of SARS-CoV-2 infection. By contrast, SARS-CoV and MERS-CoV transmission are mainly reported through nosocomial transmission. However, human-to-human SARS-CoV-2 transmission occurs mainly through close contact between COVID-19 patients or friends or carriers and between family members including relatives. It can be spread rapidly in healthcare workers (up to 50%) and patients (62-79%) similar to SARS-CoV and MERS-CoV and is considered the most common route of infection [13] . It is also assumed that consumption of wild animals who are the hosts of SARS-CoV-2 and humans in close contact with these animals are suspected to be the route of entry of SARS-CoV-2 and its mode of transmission. However, this route of SARS-CoV-2 transmission remains controversial and requires further study.

To date, 1 million people around the world have tested positive for this virus, but only 4 cases have so far been reported in which pets showed positive for SARS-CoV-2. These involved 2 dogs and 2 cats, the owners had COVID-19 and are believed to be the most likely source of transmission to their pets. The dogs showed clinical signs, but one of the cats did not have signs of illness. In late March 2020, health officials in Belgium reported that a cat from Liège province had also tested positive for SARS-CoV-2. Nevertheless, the US Centers for Disease Control and Prevention (CDC), WHO, and key animal health organizations have all issued statements aiming to calm people's fears about their pets being a source of the novel virus [14] [15] [16] . In this regard, the World Organization for Animal Health has emphasized that "there is no justification in taking measures against companion animals which may compromise their welfare". Furthermore, given the speculation that wild live animal species may be linked to this pandemic, this collaborative approach will also require the expertise of wildlife forensic specialists.

SARS-CoV-2 has also been detected in saliva, the gastrointestinal tract, urine and stool. In particular, the gastrointestinal tract or digestive tract has been recognized as another route of SARS-CoV-2 infection based on a bioinformatics study [17] . SARS-CoV-2 has been detected in gastrointestinal mucosal tissue of COVID-19 patients [18] . In addition, it has also been detected in tears and conjunctival secretions of COVID-19 patients [19] . Intrauterine vertical transmission from pregnant women to the newborn is temporarily excluded due to a lack of adequate data on pregnant women infected with SARS-CoV-2 [20] .

A number of researchers estimated the basic reproduction number (R 0 ) to calculate the number of people affected by secondary infections. Generally, it represents the number of people with COVID-19 but in a completely susceptible population without intervention [21] . Using the SEIR model, Wu et al [22] recorded an R 0 value for SARS-CoV-2 in the range of 2.47-2.86, while Majumder and Kenneth[23] estimated the R 0 value to be 2.0-3.3 based on the IDEA model. By contrast, other β-CoV viruses namely SARS-CoV and MERS-CoV showed an R 0 value in the range of 2.2-3.6 and 2.0-6.7, respectively[24,25], which indicated that SARS-CoV-2 has higher transmissibility than SARS-CoV and MERS-CoV. In China, 87% of cases were in the age group 30 to 79 years and 3% cases were noted to be aged ≥ 80 years, while female cases were only 41.9% [26, 27] . Additionally, 81% of cases were classified as mild, 14% cases were severe and 5% cases were very critical. In another study, it was reported that the overall casefatality rate (CFR) was 2.3%; however, in the age groups 70-79 and ≥80 years, the CFRs were 8.0% and 14.8%, respectively [22] . These findings clearly indicated that elderly males are more susceptible to SARS-CoV-2 compared with other groups. In addition, the virus affected those elderly males with chronic diseases such as diabetes, hypertension, heart disease, etc. [20] . In summary, the prevalence of COVID-19 is very high, and it can spread very rapidly within countries and outside countries.

Generally, elderly people aged between 55 and 75 years are more susceptible to SARS-CoV-2 infection. Currently, it has been found that the virus is also infecting middleaged people aged between 25 and 50 years. 

Genomic structure SARS-CoV-2, a β-coronavirus, is a single-stranded RNA virus with a diameter ranging between 80 nm and 120 nm. Currently, four types of coronavirus are present in nature: α-, β-, δ-and γ-coronavirus. The γ-and δ-CoV infect birds, while α-and β-CoV infect mammals. Details of these coronaviruses are presented in Table 1 . There are six coronaviruses causing human infection including SARS-CoV and MERS-CoV. The complete genome sequence of SARS-CoV-2 is closest to SARS-like bat CoV (MG772933). There is approximately 79% homology in genome sequence between SARS-CoV-2 and SARS[9]. In addition, the complete genomic sequence of SARS-CoV-2 is approximately 29.9 kb, while SARS-CoV and MERS-CoV have a genome length of 27.9 kb and 30.1 kb, respectively [8, 32] . The SARS-CoV-2 genome contains a variable number of open reading frames (ORFs) ranging between 6 and 11 [33] . Two-thirds are located mainly in the first ORF (ORF1a/b) which encodes 16 non-structural proteins (NSP) and translates polyproteins (pp1a and pp1ab), while the remaining ORFs encode accessory and structural proteins. The remainder of the RNA virus encodes four essential structural proteins, including the spike (S) glycoprotein, small envelope (E) protein, matrix (M) protein, and nucleocapsid (N) protein, and several accessory proteins, that interfere with the host innate immune response [34] . Frameshift mutation between ORF1a and ORF1b is mainly responsible for the production of pp1a and pp1ab polypeptides that are regulated by chymotrypsin-like protease (3CLpro) or main protease (Mpro), and this process produces 16 non-structural proteins (NSPs) with the help of papain-like proteases [35] . Therefore, SARS-CoV-2 pathophysiology and virulence are thought to be linked with NSPs and structural protein functions.

The pathophysiology of COVID-19 produces pneumonia which seems to be very complex. The pathological mechanism is presented in Figure 2 . A group of researchers claimed that viral infection is caused by an immune reaction through the "cytokine storm" [36, 37] . The main protagonist of this "cytokine storm" is interleukin 6 (IL-6). Generally, activated leukocytes are primarily responsible for IL-6 production and IL-6 acts on a number of cells and tissues. It stimulates acute phase protein production and regulates thermoregulation, bone structure and central nervous system functions [36, 37] . However, its main role is pro-inflammatory actions. COVID-19 enhances IL-6 level, which is implicated in the pathogenesis of the cytokine release syndrome (CRS), which is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction [36, 37] .

Another group of researchers demonstrated that SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) receptor for both cross-species and human-to-human transmission [1, 38] . The virion S-glycoprotein present on the virus surface interacts with ACE2 receptors on human cells to spread the infection[39]. S-glycoprotein contains two subunits, S1 and S2. The S1 determines the virus-host range and cellular tropism in the key function domain -RBD (receptor-binding domain), while S2 is responsible for cell membrane-virus fusion by two tandem domains, heptad repeats 1 (HR1) and HR2 [40, 41] . Following membrane fusion, viral RNA is released into the cytoplasm, and the uncoated RNA is induced to produce pp1a and pp1ab polypeptides with the help of either chymotrypsin-like protease (3CLpro) or main protease (Mpro), which encode 16 non-structural proteins (NSPs) in the presence of papain-like proteases, and finally form a replication-transcription complex (RTC) in double- September 21, 2021 Volume 27 Issue 35 membrane vesicles [8] . Subsequently, the RTC replicates continuously and synthesizes sub-genomic RNAs[42] to encode accessory proteins and structural proteins. This newly formed genomic RNA, envelopes glycoproteins and nucleocapsid proteins mediated through the endoplasmic reticulum (ER) and Golgi [43] are assembled together to form viral buds. Finally, these newly formed virion-containing vesicles are fused with plasma membrane to release the virus and cause infection through mucous membranes, especially nasal and larynx mucosa, and then enter the lungs through the respiratory tract. These ACE2 receptors are very important in the spread of COVID-19. They are mainly found in the lower respiratory tract of humans. After entry through mucous membranes, especially nasal and larynx mucosa, the virus enters directly into the lungs through the respiratory tract. In the next step, the virus attacks other target organs which contain ACE2 receptors, such as the lungs, heart, renal system and gastrointestinal tract [36, 37] . Accordingly, the binding affinity of this virus-receptor has been intensively studied using different approaches. Systematic detection analysis showed that SARS-CoV-2 S-glycoprotein binding capacity with ACE2 was 10-fold higher than SARS-CoV as shown under cryo-electron microscopy of the SARS-CoV-2 S protein in pre-fusion conformation [39] . Recently, Wu et al[9] demonstrated moderate genomic and phylogenetic similarity with SARS-CoV but higher similarity with bat CoV genome sequence, particularly in the S-glycoprotein and RBD. They also found that there were no amino acid substitutions occurring in the NSP7, NSP13, envelope, matrix, or accessory proteins p6 and 8b at the protein level, except in NSP2, NSP3, spike protein, underpinning the subdomain, i.e., RBD. Another recent study demonstrated that mutation of NSP2 and NSP3 plays an important role in infection and SARS-CoV-2 differentiation. However, this mechanism of SARS-CoV-2 infection in humans via S-protein binding with ACE2 is unclear, as is the interaction strength for risk transmission. Accordingly, the WHO was also unable to clarify the mechanism of COVID-19. This has led to further investigations regarding potential human-to-human transmission and the pathophysiological mechanisms of COVID-19 outbreaks.

Being an acute respiratory infection, COVID-19 is initiated in the respiratory tract, primarily by droplets, respiratory secretions, and direct contact. After entry, the virus affects a number of organs or systems (Figure 3 ). The clinical symptoms of COVID-19 vary from asymptomatic or paucisymptomatic forms to clinical conditions. In particular, all patients are divided into general, severe, and critical patient groups. The most common clinical symptoms of COVID-19 are fever (87.9%), cough (67.7%), fatigue (38.1%), sputum production (33.4%), shortness of breath (18.6%), sore throat (13.9%), and headache (13.6%) [27, 44] . The development of these symptoms may occur within 3 d of viral infection. On the other hand, other symptoms may occur 9 d after virus infection. Of these, fever and cough are the dominant COVID-19 symptoms. The incidence of diarrhea (3.7%) and vomiting (5.0%) is very rare [27, 44] . However, it is very difficult to accurately distinguish COVID-19 from other viral respiratory infections. The CDC included loss of taste or smell, pink eye, muscle pain, intense chills, headache and sore throat as COVID symptoms. In severe cases, symptoms such as acute respiratory distress syndrome, rhinorrhea, dyspnea, gastrointestinal disorders, septic shock, mental stress, acute heart injury, sepsis, multiple organ dysfunction syndrome (MODS), secondary infection and even death may occur [8, 34] . Critical COVID-19 patients with severe respiratory failure require an intensive care unit (ICU) or ventilation support. However, the occurrence of upper respiratory symptoms and gastrointestinal symptoms are very rare compared with other symptoms. In addition to this, the elderly and those who have underlying diseases ( i.e., chronic obstructive pulmonary disease, hypertension, diabetes, cardiovascular disease) are very prone to COVID-19 and develop symptoms such as metabolic acidosis, acute respiratory distress syndrome, coagulation dysfunction and even death [8, 45] . Sometimes, COVID-19 patients experience acute heart injury, arrhythmia, impaired renal function and abnormal liver function such as the formation of microvesicular steatosis (50.7%) at the time of admission [1, 45, 46] .

Hematological assays revealed that most patients had decreased white blood cell counts, and lymphocytopenia [27] . In the case of critical patients, neutrophil count, Ddimer, blood urea, creatinine and lymphocyte levels decreased markedly. In another study, a reduction in albumin level (75.8%; 95%CI, 30.5%-100.0%), higher C-reactive protein (58.3%; 95%CI: 21.8%-94.7%) and lactate dehydrogenase (LDH) levels (57.0%; 95%CI: 38.0%-76.0%), higher lymphopenia level (43.1%; 95%CI, 18.9%-67.3%), and higher erythrocyte sedimentation rate (ESR) (41.8%; 95%CI: 0.0-92.8%) and other clinical manifestations were recorded [28] . Additionally, inflammatory factors, which indicated the immune status of patients, namely IL-6, IL-10, and tumor necrosis factorα (TNF-α) are also markedly increased. In critical patients (admitted to the ICU), higher IL-2, IL-7, IL-10, granulocyte colony-stimulating factor (GCSF), 10 kD interferon gamma-induced protein (IP-10), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein 1-α (MIP-1α), and TNF-α levels in plasma were observed [8, 45] . In patients with severe COVID-19 [admitted to the ICU; 20.3% cases (95%CI, 10.0-30.6%)], 32.8% of patients experienced ARDS (95%CI: 13.7%-51.8%), 13.0% patients had acute cardiac injury (95%CI: 4.1%-21.9%), 7.9% patients experienced acute kidney injury (95%CI: 1.8-14.0%), 6.2% cases (95%CI: 3.1%-9.3%) developed shock and 13.9% cases (95%CI 6.2%-21.5%) experienced fatal outcomes [28] . Furthermore, 96.8% of all patients (95%CI: 94.9%-98.7%) had RNAemia in blood and nasopharyngeal aspirates (NPA)[28].

Immunological symptoms are generally caused due to binding of virus S proteins with ACE2 at the receptor, usually in the endosome Toll-like receptor (TLR) 3, TLR7, TLR8, and TLR9 [8, 47] . Retinoic-acid inducible gene I (RIG-I) of the virus, melanoma differentiation-associated gene 5 (MDA5) of the cytosol and nucleotidyltransferase cyclic GMP-AMP synthase (cGAS) are generally responsible for the spread of COVID-19[8, 48, 49] . Viral infection activates nuclear factor-κB (NF-κB) and interferon regulatory factor 3 (IRF3) to produce type I interferons (IFN-α/β) and pro-inflammatory cytokines as immune mediators (i.e., innate immunity) to prevent infection[8,50]. As a result, the plasma levels of some cytokines and chemokines are elevated in COVID-19 patients such as IL-1, IL-2, IL-4, IL-7, IL-10, IL-12, IL-13, IL-17, GCSF, macrophage colonystimulating factor (MCSF), IP-10, MCP-1, MIP-1α, hepatocyte growth factor (HGF), IFN-γ and TNF-α [20, 45, 51] . Generally, these inflammatory responses were noted in the lower airway and lung [52] . Consequently, these trigger immune signaling and produce the "cytokine storm' within the body leading to a very critical condition in COVID-19 patients. September 

Since the outbreak of COVID-19, a number of diagnostic tools have been used to detect the infection. The classical Koch's postulates method was used to detect the infection in Wuhan [22] . This method is very expensive and time-consuming as it uses electron microscopy. In some countries, radiography was used to detect the viral infection such as a chest computed tomography (CT) scan. CT scan is an important tool in diagnosing COVID-19 pneumonia. Typical COVID-19 pneumonia features were observed by CT. and CT imaging showed ground-glass opacities (56.4%-65%), an air bronchogram (47%), bilateral patchy shadowing (51.8%), consolidations (50%), smooth or irregular interlobular septal thickening (35%), thickening of adjacent pleura (32%), sometimes rounded morphology, peripheral and lower lobe involvement and a peripheral lung distribution in COVID patients [27, 53, 54] . A very recent study recorded bilateral chest CT findings in 90% patients, and proved its sensitivity (97%) in detecting COVID-19

[55]. However, in another study clinical scientists found that some patients with confirmed COVID-19 had normal CT scans [53] . Therefore, the diagnosis of COVID-19 is very confusing. Moreover, this technique mainly determines pneumonia. Accordingly, scientists are looking for an alternative method which is more reliable and confirmative. The detection of viral nucleic acid from nasal and throat swab samples, cough, sputum or other respiratory tract samples is the golden diagnostic method for COVID-19 detection. This method uses RT-PCR technology to detect viral infection. Although, this method has high specificity, false-negative results may occur due to low sensitivity and the testing time is too long. In the case of false-positive tests, the WHO recommends resampling and further testing. In this regard, serologic testing is an important diagnostic tool to detect patients who have either current or previous infection but have a negative PCR test [56, 57] . In this technique, basic parameters are tested to detect the COVID-19, namely white blood cell count, neutrophil and lymphocyte count, D-dimer, blood urea, and creatinine estimation to identify the appearance of leukopenia, leukocytosis, and lymphopenia as COVID- However, clinical verification of these technological inventions has not been undertaken to date, and once approved, they will be a major breakthrough in technology to diagnose COVID-19 rapidly and economically.

Since its outbreak in Wuhan, China in late December 2019, SARS-CoV-2 infection is spreading very rapidly across the globe. COVID-19 has affected 202608306 people and caused around 4293591 deaths ( Table 2 ). The inter-continental spread is described in Table 2 . Figure 4 shows COVID-19 outbreaks in different countries. In the beginning, the Asian countries namely China and South Korea were the epicenter of COVID-19 until the first week of February. Up to August 10, 2021, there have been 93826 confirmed cases and 4636 deaths in China (WHO). In Korea the first COVID case was recorded on January 20, 2020. Since then, about 212448 cases have been confirmed and 2125 deaths recorded in Korea. The epicenter then moved from Asian countries to European countries mainly Italy and Spain. COVID-19 was recorded in Italy on January 30, 2020, and was found in France and Spain on January 24, 2020 and January 31, 2020, respectively. In particular, in Italy, the United Kingdom, France, Germany and Spain it affected people more seriously; approximately 4400617, 6094243, 6310933, 3800048, and 4627770 confirmed cases and 128242, 130357, 112288, 92291, and 82125 deaths were recorded in these countries, respectively, up to August 10, 2021. Among the European countries, mortality rate was highest in Italy due to its travel connection with China. In the middle of March, the virus epicenter moved to the United States and other American countries. The United States and Canada were the most affected countries during this phase. Although the first COVID-19 patient was recorded in late January, 2020 the first death was confirmed in February. In the USA, the first COVID-19 patient died in the middle of March. On August 10, 2021, the USA had recorded the greatest number of confirmed cases and deaths worldwide. The death rate is 206 per million people, which is the tenth highest rate globally. The first COVID-19 patient in Canada was reported on January 27, 2020. On August 10, 2021 there have been 36780480 and 1442087 confirmed cases in the USA and Canada, respectively, and 633799 and 26678 deaths, respectively. In the middle of April, the virus epicenter moved to Russia and India. As of August 10, 2021, there have been 6469910 and 31997017 confirmed cases in Russia and India, respectively, and the number of deaths is 165650 and 428715, respectively. However, the first confirmed COVID-19 case was recorded on January 30, 2020 in Kerala state and January 31, 2020 in Russia. The virus infection in these countries took a very long time to spread due to the implementation of different control measures. The details of COVID-19 cases in India are presented in SARS-CoV-2 infected people as well as other diseases such as influenza viruses, including H7N9 by reducing inflammatory factors [1, 17] . [70] indicated that Glycyrrhiza glabra also has antiviral and antimicrobial activities. Therefore, Glycyrrhiza glabra plant extract along with other plants may be useful in controlling COVID-19. Accordingly, the Government of India has recommended Ayurveda treatment methods to improve immunity (Table 5 ).

Arsenic album-30 is considered beneficial for viral infections. Recently, the Directorate of AYUSH, New Delhi, India has issued an order on January 30, 2020 to take prophylactic medicine to avoid coronavirus infection. Dr Rajan Sankaran has recommended Camphor 1M as a potential medicine for COVID-19 (https://www.boomlive.in/ coronavirus-outbreak/homoeopathy-can-be-used-as-adjuvant-to-covid-19-treatmentdr-anil-khurana-7997). They recommended 4 pills of Arsenic album-30 medicine once daily on an empty stomach for 3 d. It is highly diluted arsenic trioxide and works as a homeopathic prophylaxis. Accordingly, the Homeopathy Department of Kerala Government is administering Arsenicum Album 30C as a preventive medicine to boost immunity in COVID-19 patients and it was approved by the Department of AYUSH, GoI (https://gulfnews.com/world/asia/india/covid-19-kerala-governmentdistributes-homeopathy-medicine-to-boost-immunity-1.1588091249686). However, to date, there is no clinical evidence that Arsenic album-30 is an effective medicine. As a result, the use of these medicines to manage COVID-19 has been criticized globally. Mathie et al [71] reported that Arsenicum album medicine is effective in reducing fever, runny nose, headache, and sore throat in patients with swine flu. Therefore, the use of homeopathy in COVID-19 management is debatable and requires further scientific study.

Boosting the body's immunity is a potential individual protocol as COVID-19 pathogenesis is caused by a disproportionate immune response. Therefore, it is important to take supplements to boost both innate and adaptive immune response.

Interferon is reported to inhibit viral infection and in particular, recombinant interferon α is effective for SARS-like viruses. Additionally, interferon was reported to be an effective inhibitor of MERS-CoV replication[72]. These findings indicated that interferon could be used to treat COVID-19 infection. Intravenous immunoglobulin might be the safest immune modulator for all age groups, and could help to inhibit pro-inflammatory cytokine production and to increase anti-inflammatory mediators [1, 73] . Moreover, thymosin alpha-1 (Ta1) is used as an immune booster for SARS patients to effective control the disease [74] . Accordingly, intravenous immunoglobulin and Ta1 may also be used for the treatment of COVID-19. Recently, different immune-booster drugs have been used to treat COVID-19 such as neuraminidase inhibitors (e.g., oseltamivir used to treat influenza). Apart from these, citrus fruits, dry fruits (almonds, walnuts, and dates) are very effective in improving the immune system. Vitamin A, C, D and E, and zinc supplements are effective in older patients. Additionally, adequate sleep, regular exercise and stress avoidance is essential to boost the immune system[68].

Due to lack of appropriate vaccines and specific drugs, plasma therapy could be an effective way to treat COVID-19. Previously, convalescent plasma therapy was proved to be an effective treatment option for SARS patients and those with H1N1 influenza [75, 76] . From an immunological perspective, it was observed that recovered COVID-19 patients produced specific antibodies against SARS-CoV-2, and therefore their serum could be used to prevent re-infection. Additionally, these antibodies can limit the September Berg-e-Gaozabaan 7 g

Any of them @12 g (each)

production of virus in the acute phase and help to clear the virus if injected during the first week of the viremia peak. Therefore, plasma globulin specific to SARS-CoV-2 has to be prepared from recovered COVID-19 patients. Recently, the Delhi Government successfully applied plasma therapy to treat COVID-19 patients. In summary, in addition to the abovementioned treatments for COVID-19, auxiliary blood purification treatment (mainly used for severe NCP patients) could be used as an alternative therapy. According to Zarbock et al [77] the ACE2 receptor, the key receptor of SARS-CoV-2, is highly expressed in human kidney (100 times higher than in the lung). Kidney is one of the target organs for SARS-CoV-2; therefore, continuous blood purification could reduce renal recovery during COVID-19. Additionally, the kidney suffers from cytokine storms under severe COVID-19 infection. Therefore, blood purification technology could be an alternative method for removing inflammatory factors, eliminating cytokine storms, correcting electrolyte imbalances and maintaining acid-base status [1] . In addition, randomized double-blind clinical trials should be used as standard methodology for large sample sizes to determine antiviral drug efficacy in clinical practice. Currently, in India the discharge policy for COVID-19 recovered patients is based on 3 tier COVID-19 facilities and the categorization of patients is based on clinical severity. The revised discharge policy is indicated in Figure 5 .

COVID-19 has affected all sectors of society. Therefore, prevention is the best practice to reduce the impact of COVID-19 considering the lack of effective treatments. This can be achieved through a variety of means as follows:

Individual measures are essential in reducing the spread of COVID-19 at the community level. Community level spread is mainly caused when an infected person is in close contact with other healthy individuals. According to the WHO, the following individual measures should be taken to reduce the contamination level such September 21, 2021 Volume 27 Issue 35 as the use of face masks; respiratory hygiene by covering the mouth and nose with a bent elbow or tissue during coughing or sneezing; washing hands regularly with soap or disinfectant (containing at least 60% alcohol); avoiding contact with infected people, maintaining an appropriate distance (at least 2 m) from coughing or sneezing people; refraining from touching eyes, nose, and mouth with unwashed hands and finally, following advice from the healthcare provider.

Social lockdown is the restriction of inter-individual physical contact. Generally, it is a community level measure. The prime objective of social lockdown is to avoid two people from different families or nearby inhabitants coming in close contact with each other [78] . However, minimal and emergency movement of the general public is allowed under this condition. The emergency services (medical care, food security, general security and medicine supply) vary in different countries. However, in severe situations, emergency services such as the food and medical supply chain can also be closed as external or internal body fluid discharges such as coughs, sneezes, saliva etc. from COVID-19 patients infect healthy persons due to its easy transmissibility. Another objective of social lockdown is to allow the community to develop mild or full resistance to a mutated virus [78] . Moreover, it provides researchers more time to work on medicine or vaccines production. Considering the advantages of social lockdown, many nations across the globe have started different degrees of social lockdown to prevent SARS-CoV-2 infection.

Some of the international social lockdown campaigns have been addressed here to understand COVID-19 preventive measures. Since the outbreak of COVID-19, China was the first country to implement social lockdown, which occurred in the last week of January 2020 in Wuhan city, the epicenter of the COVID-19 outbreak. During lockdown, buses and cars were allowed to run but domestic flights and trains were cancelled in various cities, and around 760 million people were under lockdown [29] . Accordingly, the WHO praised China as they had taken "perhaps the most ambitious, agile and aggressive disease containment effort in history" [79] [80] [81] . After China, Italy was the second country to adopt social lockdown. In Italy, social lockdown was declared on February 21, 2020 in northern Italy covering only 50000 people. Considering the disease incidence, the Federal government of Italy declared whole country lockdown on March 9, 2020. Only public transport was partially allowed, and a public pass system was initiated to ride buses or board flights on an emergency basis [82] . September COVID-19 in the USA was spreading very rapidly with a high death rate since its first official COVID-19 case. Higher infection was mainly due to either higher migrant movement or a higher rate of clinical diagnosis [83] . Hence, following the high death and infection rate in the USA, the Trump government implemented the first lockdown on March 19, 2020 but to achieve total control of COVID-19, the American government extended the lockdown period to April 30, 2020 on March 30, 2020. The Trump government explained the second lockdown as follows "The better you do, the faster this whole nightmare will end. Therefore, we will be extending our guidelines to April 30th to slow the spread." Accordingly, the Director of NIH recommended the people of the USA to adapt to the lockdown voluntarily and stringently [84] . Most of the African countries had started to implement social distancing in the middle of March and ended it between May 10 and May 20, 2020. The same window was also used by most European countries. Social distancing in Bangladesh was implemented by Prime Minister Sheikh Hasina very late on March 25, 2020 and ended on May 16, 2020. Other countries such as Pakistan and Sri Lanka started to implement social distancing on March 24, 2020 which ended on May 9, 2020. Additionally, Sri Lanka declared a curfew to maintain strict social distancing.

Being a populous country, a large portion of the population lives in places of high density and their unhygienic lifestyle results in frequent infectious and epidemic diseases [85] . Therefore, as World Bank data have indicated India is still struggling to improve its health care system and is unable to provide sufficient hospital beds for its citizens. India can only afford 0.7 hospital beds per 1000 people, the doctor: population ratio is 1:1800 (standard is 1:1000), and the total number of ventilators available is 48000 [86] . Considering this, the Government of India under Prime Minister Narendra Modi declared a Janata Curfew for 14-h (from 7 a.m. to 9 p.m.) on March 22, 2020 prior to total lockdown. Except for 'essential services' (police, medical services, media and home delivery) everyone took part in the curfew. According to Swiss firm IQAir, at least 75 Indian districts took part and helped to control the spread of SARS-CoV-2, which had an immediate positive effect, especially in Delhi, which is known as one of the world's most polluted capital cities. This resulted in a massive change in New Delhi's Air Quality Index (AQI). This was mainly due to a huge reduction in vehicular traffic; during lockdown there was a 70% reduction in the demand for petroleum oil. India is the third largest user of oil, after the USA and China. After that a nationwide lockdown for 21 days (except emergency services) was declared on March 24, 2020. The government implemented the following restrictions: (1) ban on people from stepping out of their homes; (2) closed all services and shops except pharmacies, hospitals, banks, grocery shops and other essential services; (3) closed all commercial and private establishments (only work-from-home allowed); (4) suspended all educational, training, and research institutions; (5) closed all places of worship; (6) suspended all non-essential public and private transport; (7) prohibited all social, political, sports, entertainment, academic, cultural, and religious activities; and (8) suspended entry of all international commercial flights from March 22. During the first phase of lockdown, the infection rate was not as high as that in the USA, Spain and Italy. It was previously reported that temperature may adversely affect virus infection [87] . Considering the influence of the upcoming Indian hot and humid summer, the health experts urged the Government to extend the lockdown. Many international news agencies described this strict lockdown by the Indian government as harsh, intensive and mismanaged [88, 89] . However, the WHO declared that "the measures taken by India to break the community spread of COVID-19 by the lockdown was a very early, scientific and timely decision" [90] . In the words of Dr. David Nabarro, special envoy on the disease, WHO "The lockdown in India was quite early on, when there was relatively a small number of cases detected. This was really a far-sighted decision because it gave the whole country the opportunity to come to terms with the reality of this enemy. People understood that there is a virus in our midst. It gave time to develop capacities at the local level for interrupting transmission and sorting out hospitals. Of course, there is a lot of debate and criticism, and inevitably with a lot of frustration and anger that life is being disturbed in this way. It is very, very upsetting. I think it is courageous of the government, honestly, to take this step and provoke this enormous public debate and let the frustration come out, to accept that there will be hundreds of millions of people whose lives are being disrupted. For poor people on daily wages, this is a massive sacrifice they are making. And to do it now at an early stage as opposed to waiting three or four weeks later when the virus is much more widespread was very courageous [91] ."

In the second phase, PM Modi extended the nationwide lockdown on April 14, 2002 until May 3, with a conditional relaxation after April 20. On April 16, lockdown areas were classified as "red, orange and green zones", indicating the presence of infection hotspots, some infection, no infections, respectively. On April 20, the government announced relaxations in different sectors such as agriculture including dairy, aquaculture and plantations, selling of farming products, cargo transportation including trucks, trains and planes following social distancing norms [92] . On April 25, the government allowed the opening of small retail shops with half-staff following social distancing norms. On April 29, the Ministry of Home Affairs allowed inter-state movement of migrant people following the guidelines laid down by the government. An additional extension (May 4 -May 17) was granted by Government of India on May 1, 2020 with additional relaxation to curb the infection.

In this phase, the whole country was categorized into three zones namely red zones (130 districts), orange zones (284 districts) and green zones (319 districts). Red zones were areas with high infection and a high doubling rate, orange zones had comparatively fewer cases and green zones had no cases in the past 21 days. Normal movement was allowed in green zones with buses (50% capacity). In orange zones, only private and hired vehicles but no public transportation was allowed, while red zones were under complete lockdown. The government then implemented a fourth phase of lockdown to prevent COVID-19 between May 18 and May 31, 2020. On May 30, the government extended the ongoing lockdown until June 30 for only containment zones with services resumed in a phased-manner from 8 June. This was termed "Unlock 1.0". The second phase of unlock, called Unlock 2.0, was announced for the period of 1 to 31 July, followed by the easing of restrictions. Currently, Unlock 3.0 has been announced for August.

The lockdown period has greatly helped the environment to rejuvenate, simply due to a reduction in pollution level to a large extent.

SARS-CoV-2 can remain suspended for approximately 30 min as an aerosol (< 5 μm). SARS-CoV-2 remained viable in aerosols for up to 3 h, with a reduction in infectious titer from 10 3.5 to 10 2.7 TCID 50 per L of air. SARS-CoV-2 is more stable on plastic and stainless steel than on copper and cardboard [78] . The virus has the longest life on plastic and steel, surviving up to 72 h but the total number of virus particles decreases sharply over this time (10 3.7 to 10 0.6 TCID 50 per mL of medium after 72 h on plastic and 10 3.7 to 10 0.6 TCID 50 per mL after 48 h on stainless steel). On copper, it survives up to 4 h [78] . On cardboard, it survives up to 24 h, which suggests packages that arrived in the mail should have only low levels of the virus. On copper and cardboard, the virus is undetectable by 8 and 48 h, respectively [78] . The half-life of SARS-CoV-2 is similar to SARS-CoV-1 in aerosols, with a median of approximately 1.1 to 1.2 h and 95% credible intervals of 0.64 to 2.64 for SARS-CoV-2 and 0.78 to 2.43 for SARS-CoV-1 [78] . The halflife of these two viruses is also similar on copper. On cardboard, the half-life of SARS-CoV-2 is longer than SARS-CoV-1. The longest viability was detected on stainless steel and plastic; the estimated median half-life of SARS-CoV-2 is 5.6 h on stainless steel and 6.8 h on plastic [78] .

The COVID-19 pandemic is spreading globally irrespective of meteorological influence. Meteorological factors such as temperature, weather conditions and humidity are thought to play a vital role in COVID-19 transmission. At the beginning of the outbreak, it was speculated that COVID-19 may decrease with increasing air temperature as the outbreak occurred in the winter months [93] . Additionally, air temperature was relatively low in those months in comparison with Spring and/or Summer months. Accordingly, Zhou and Xie [94] demonstrated there is no concrete evidence of a decrease in COVID-19 when ambient temperature increases. Recently, Ma et al [95] indicated the positive influence of temperature and humidity on COVID-19 i.e., increase in temperature and humidity decreases the number of COVID-19 deaths. This study was also conducted in same time period (January-February) as the study by Zhou and Xie [94] . A similar positive influence of meteorological factors on COVID-19 in various countries [96, 97] was demonstrated. In addition to meteorological factors, Ramadhan [96] highlighted very high mobility and high density of people resulted in fast transmission of COVID-19 in Jakarta. September 21, 2021 Volume 27 Issue 35

Influence on air quality transmission has a direct impact on air quality namely particulate matter, SOx, NOx and carbon, etc. Standard air quality is essential in maintaining human health. However, almost 91% of the world's population lives in very poor air quality that exceeds the permissible limits [98] , resulting in approximately 8% of deaths globally mainly in Asia, Africa and parts of Europe [98] . Coccia [99] demonstrated that cities (North Italy) with poor air quality (PM 10 or ozone) increased the probability of COVID-19, mainly due to air pollution-to-human rather than human-to-human transmission. Another study from the same city indicated that prolonged exposure to poor air quality (PM 10 , PM 2.5 , O 3 , SOx and NO 2 ) boosts COVID-19 incidence and even death in elderly people who have severe respiratory and cardiovascular disorders [97] .

On the other hand, COVID-19 has significantly improved the air quality globally, particularly during lockdown periods due to the cessation of social activity, industrial activity, institutional activity, etc. Columbia University reported that the amount of carbon monoxide and carbon dioxide in New York City was reduced by 5% and 10%, respectively. During February 2020, carbon emission was decreased by 25% in China, which was last recorded during the economic crisis of 2008-2009. NASA's OMI instrument measured a 36% reduction in NO 2 concentration in China as well as in Italy, Spain, and France during February 2020 (these countries declared lockdown before other European nations). The level of particulate matter (PM 2.5 ) in London, Cardiff, and Bristol was less following the implementation of lockdown. PM induces inflammation in lung cells and exposure to PM increases the susceptibility and severity of COVID-19 symptoms.

In China, there was a profound decline in air pollution (greenhouse gases) during January and February as recorded by NASA using satellite images due to the decrease in industrial, business and transportation activity. Accordingly, the China's Ministry of Ecology and Environment declared that it is 'good quality, air days'.

An approximately 43%, 31%, 10%, and 18% decrease in PM 2.5 , PM 10 , CO, and NO 2 levels, respectively, were observed in India during COVID-19 lockdown compared to previous years [100] . The AQI was reduced by 44%, 33%, 29%, 15% and 32% in north, south, east, central and western India, respectively. In New Delhi, the AQI was reduced to as low as 93, and in Mumbai it decreased to 90 from 161 and 153, respectively.

Due to quarantine, NO 2 level was reduced by 22.8 μg/m 3 and 12.9 μg/m 3 in Wuhan and China, respectively. PM 2.5 level dropped by 1.4 μg/m 3 in Wuhan but in another 367 cities it was decreased by 18.9 μg/m 3 [103] . After two weeks of lockdown in Spain, the black carbon and NO 2 level decreased markedly (-45 to -51%)[102]. However, O 3 level increased (+33 to +57%, 8 h daily), probably due to lower titration of O 3 by NO due to lower NOx level [102] . Additionally, the Copernicus Atmosphere Monitoring Service (CAMS) of the European Union observed a drop in PM 2.5 level during February 2020 in comparison with the previous three years. In China, according to CAMS [103] , an approximately 20%-30% decrease in PM 2.5 was recorded in different parts of China during February 2020 compared with monthly averages in February 2017, 2018 and 2019. It is likely that the improvement in air quality around the globe was recorded due to COVID-19 control measures mainly by lockdown and quarantine [104] [105] [106] [107] [108] . During this period the demand for petroleum oil was reduced by 20% worldwide.

Furthermore, different national and international media on 10 th February reported increased SO 2 concentration of approximately 1,350 µg/m 3 in Wuhan and Chongqing cities due to mass cremation of COVID-19 victims based on a screenshot image from windy.com. These were the results of the GEOS-5 Model. On the other hand, The Sun showed that this was not certain but mainly due to the cremation of virus-infected victims. Accordingly, The Sun (https://archive.is/ShAfz), WION (https://archive.is/ Cdz4d) and IndiaTimes (https://timesofindia.indiatimes.com/times-fact-check/ news/fact-check-satellite-images-showing-high-levels-of-sulphur-dioxide-indicatemass-cremations-in-china/articleshow/74130633.cms) demonstrated that the mass cremations in Wuhan and Chongqing cities could be the prime reason for increased SO 2 concentration. Dr Arlindo M da Silva, from the Global Modeling and Assimilation Office, stated that GEOS-5 sulfur dioxide models do not "assimilate real satellite data" to confirm the image of windy.com. The China National Environmental Monitoring Center and the Center for Satellite Application on Environment and Ecology and the Chinese Academy of Sciences explained that the SO 2 data fluctuated between 4 and 8 µg/m 3 , which was over 200 times less than the data shown on the website.

Environmental noise produced mainly by industrial or commercial operations, transit vehicles, and many other sources cause serious health problems in the population [109] . The implementation of quarantine and lockdown due to COVID-19 preventive measures by most governments around the globe has compelled people to stay at home. The use of private and public transportation including trains and planes decreased significantly. Additionally, all commercial activities, shopping complexes and industrial operations stopped almost entirely. Accordingly, it is thought that noise level should have reduced; however, there are currently no studies on this issue. Most studies are confined to air quality assessment. Therefore, more attention should be focused on this environmental aspect.

Water quality in freshwater and marine ecosystems is also expected to improve globally. The lack of tourists, as a result of social distancing, has caused a significant change in beaches around the world. Coastal areas are important natural assets, which provide recreation and tourism, and fishing activities. These services are crucial for the nutrition and survival of coastal animals and human communities, and impart intrinsic values [110] . The lack of tourists has resulted in less pollution, especially plastics and wastes as well as reduced drainage volume into water bodies. A lower pollution level in aquatic ecosystems improves the health of the ecosystem by improving the health of aquatic organisms. In undisturbed habitats, olive ridley turtles were able to lay their eggs in Odisha's Gahirmatha beach and Rushikulya roockery. A number of dolphins were observed jumping in the water at the Marine Drive of Mumbai in the Arabian Sea, and the Canals of Venice are now full of fish and dolphins, as the water has sufficient time for sediments to settle to the bottom. According to Sunita Narain, the environmental activist, also the Director General of the Centre for Science and Environment (CSE), explained that, "Right after this health crisis subsides, it is imperative to get the economy back in shape. People need to get back to work and continue leading their lives. This is just a phase. People can learn from it. However, we require long-term solutions like that of the utilization of clean energy, conservation of forests, and efficient waste management systems in order to see real impact." According to R. Ramamurthy, COVID-19 is an eye-opener. For example, beaches such as those of Acapulco (Mexico), Barcelona (Spain), or Salinas (Ecuador) are now cleaner with crystal clear waters [101] . This aspect also needs further study to understand the impact of COVID-19.

A number of environmental issues such as air and water pollution, soil erosion, and deforestation are responsible for direct or indirect generation of organic and inorganic waste [111] . Home quarantine measures, established across most countries as COVID-19 measures, have expanded online shopping dramatically. Accordingly, online procurement systems enhanced the generation of inorganic waste due to packaging, in addition to enhanced organic waste generation by households. Furthermore, medical waste generation is also high. In Wuhan, around 240 metric tons of medical waste is generated per day since the COVID-19 outbreak, which is too high compared with previous years (average 50 tons) [45] . Calma [112] reported that in countries like the USA garbage generation due to personal protective equipment such as masks and gloves have increased significantly compared with previous years.

Waste recycling is a common and effective way to prevent pollution, save energy, and conserve natural resources; simultaneously, it is a major environmental problem across the globe [113, 114] . Although wastes are generated in high volume globally, at present it is impossible for all countries to recycle these wastes due to the further spread of SARS-CoV-2 infection. Accordingly, the USA has closed waste recycling totally due to COVID-19. Affected European countries have also restricted waste management during this outbreak [101] . For example, Italy totally prohibited infected residents from sorting their waste. Industry also seized the use of reusable bags, as single-use plastic can harbor viruses [115] . China has implemented the use of additional disinfectant in wastewater treatment plants to strengthen their disinfection process to prevent the new coronavirus spreading via wastewater. However, to date, there is no evidence of the survival of SARS-CoV-2 in drinking water or wastewater [116] .

Wildlife is also affected by SARS-CoV-2. In a USA sanctuary, one tiger was reported to be coronavirus positive. In a Chinese sanctuary, two pangolins died due to the virus infection. It also affected the movement of migratory birds. Different migratory birds are now visiting places where they never visited before due to high pollution levels. It has also forced the UN organization to postpone the Annual Climate Change Conference, i.e., COP-26, which was scheduled to be held at Glasgow in the UK in September 21, 2021 Volume 27 Issue 35

November 2020.

COVID-19 outbreaks have adversely affected different sectors of society with big losses globally in terms of both monetary and personal loss, which cannot be accurately estimated. However, some aspects can be addressed here. Globalization is a chain process; therefore, it will collapse if a single chain stops working. In particular, the economy of countries is adversely affected. Functions, especially business meetings, sports events, scientific conferences, running educational institutes, fashion shows, and wedding parties are to be avoided, which has a big social impact on society. In the educational sector, many countries banned the running of schools, colleges and universities as well as students attending classes, which has deprived the students of a good quality education. This loss poses a large problem not only in monetary matters but also a big disadvantage to the students and their families mainly due to psychological stress. Apart from this, the tourism sector and industrial sectors are facing a major problem due to lack of labor. Prices of commodities are increasing, which has had a negative impact on poor people worldwide. Implementation of lockdown has had an enormous negative impact on poor people especially their daily wage as they are unable to earn. According to the ILO, half of permanent employees will be deprived of work, particularly in the Asia and Pacific regions. In India, 90% of workers from unorganized sectors were highly affected. In addition, production in eight major sectors was reduced by 6.5%, which obviously affected the industrial production index. According to an estimate by the IATA there was a loss of about $113 billion during the lockdown period so far. However, the positive effect of social lockdown is spending more time with family members as well as friends but without physical meetings. It has positive effects on health and accordingly improves immunity. This pandemic has had a serious impact on major festivals around the world, which may lead to secondary epidemic burnout and stress-related absenteeism. The Public Health Department of England has mentioned 14 ways to protect mental health during the pandemic. The WHO has recommended two most effective protocols, the R-TEP (Recent Traumatic Episode Protocol) and G-TEP (Group Traumatic Episode Protocol) to treat the invisible and psychological wounds of trauma in these situations. 'The Lancet' documented the psychological impact of quarantine in people which included low mood, insomnia, stress, anxiety, anger, irritability, emotional exhaustion, depression and post-traumatic stress symptoms. Some people have a higher risk because of long-term absenteeism from work due to illness and burnout, which has led to a loss of productivity of approximately 35% in these workers (America's State of Mind Report). In the case of patients who are in quarantine with their children they are facing major mental disorders such as trauma-related health disorder.

It is obvious that this pandemic has both long-and short-term implications on public mental health. Poor mental health may be the result of social isolation and loneliness. It is reported that 47% cases showed negative mental health effects due to worry or stress related to coronavirus, in particular, the situation is very pronounced among older adults and households with adolescents. Research has shown that older adults are at higher risk of poor mental health due to loneliness and bereavement. It also showed that job loss enhances depression, anxiety, distress, and low self-esteem and a higher rate of disorders. In the USA, 30 million students and subsequently their families face physical, social, and mental health impairment. During this pandemic, mental health illness among adolescents has been exacerbated, and over 12% of adolescents aged between 12 and 17 years have depression and/or anxiety. Closures of non-essential businesses and disruption to livelihood have a negative impact on mental health. It has been observed that people with low incomes (about 26%) experience major negative mental health impacts (worry, 17% and stress, 14%) compared with high income groups. Presently, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) endorsed the need for emergency services to improve the mental health conditions of remote people. According to the CDC, people who suffer from chronic illness such as chronic lung disease, asthma, chronic cardiovascular disease, and diabetes are at high risk of severe illness due to COVID-19. September 21, 2021 Volume 27 Issue 35 

Although a large number of individuals recover from COVID-19, the incidence of SARS-CoV-2 RNA recurrence has been recorded in various countries. To date, the incidence of recurrent SARS-CoV-2 in recovered individuals ranges from 7.35 to 21 [120] reported the recurrence of COVID-19 in a 48-year-old man from Italy who developed dyspnea and chest pain. The recurrence of COVID-19 has been reported around the world, and raises questions about the durability and quality of immune protection from SARS-CoV-2 as well as the quality of treatment options.

COVID-19 has been an unprecedented disaster around the globe in every aspect, especially environmental health, social and economic aspects. This pandemic originated from bats. People worldwide are consuming different animals including bats, cats, snakes, mice, rats, pigs, dogs, etc., as food stuff. Accordingly, our future generation must be provided with substantial knowledge before consuming these animals as food. Furthermore, people should be informed about the negative impact of these foods as they may harbor dangerous microbes. Emphasis should be given to providing adequate health care facilities to all people across countries including a greater number of health care systems, health insurance etc. This pandemic has highlighted the lack of health care facilities across the globe. Therefore, investment is needed in science and technology to establish specialized research centers to fight against such disasters in the future. In addition, more scientific studies are needed especially on viral diseases, mosquito-and insect-based diseases, bacterial infections, cancer, etc., to combat any future pandemics. Currently, no medicine or vaccines have been identified to treat or eradicate COVID-19. Therefore, efforts should be focused on developing effective medicine or vaccines to treat COVID-19 through technological advancements.

This review provides an insight into the current status of COVID-19 (to date) from an environmental perspective. COVID-19 is a zoonotic disease, which originated from bats in Wuhan, China and was declared a pandemic by the WHO. The main symptoms are high fever, cough, shortness of breath and fatigue, which are similar to those of SARS. COVID-19 is highly infectious and transmissible through either aerosol droplets or close contact. The virus has spread to 213 countries/territories with approximately 202608306 confirmed cases and 4293591 deaths up to August 10, 2021. SARS-CoV-2 binds to human ACE2 and infects humans. Elderly people are more prone to SARS-CoV-2 compared to other age groups. To date, there is no specific medicine or vaccines for COVID-19. Currently, drugs such as remdesivir, chloroquine, hydroxychloroquine, tocilizumab, lopinavir-ritonavir, azithromycin, etc., are used to treat SARS-CoV-2 infection. However, no drug is able to induce full recovery in COVID-19 patients. Remdesivir is effective in treating the virus. Recently, the ChAdOx1 vaccine was developed by the University of Oxford's Jenner Institute and the Oxford Vaccine Group. More recently, Russia has developed a coronavirus vaccine, named Sputnik V but these are still in the testing phase. Therefore, boosting the immune response could be an effective way to improve viral resistance. Accordingly, prevention and management are currently the best solution to control COVID-19. Therefore, it is essential that we follow the preventive measures, management and quarantine strictly laid down by the concerned government ( Figure 6 ). Source reduction as an individual protective measure is the best way to control the infection. Lockdown as a social strategy is considered an indirect, but effective alternative tool to control spread of the virus. Additionally, the pandemic has had a direct impact on the environment, society and economy. Therefore, we should promote science and technology to develop vaccines or specific drugs to combat COVID-19.

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

The reproductive number of COVID-19 is higher compared to SARS coronavirus

What do we know about the SARS-CoV-2 coronavirus in the environment?

China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China

Questions and Answers on the 2019 Coronavirus Disease (COVID-19)

Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan

Evidence for Gastrointestinal Infection of SARS-CoV-2

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Modelling environmentally-mediated infectious diseases of humans: transmission dynamics of schistosomiasis in China

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

Early Transmissibility Assessment of a Novel Coronavirus in Wuhan

Transmission dynamics and control of severe acute respiratory syndrome

Estimation of MERS-Coronavirus Reproductive Number and Case Fatality Rate for the Spring 2014 Saudi Arabia Outbreak: Insights from Publicly Available Data

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Caution on kidney dysfunctions of 2019-nCoV patients

Innate immune sensing and signaling of cytosolic nucleic acids

Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA

Sensing viral invasion by RIG-I like receptors

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

2019-novel coronavirus (2019-nCoV) infections trigger an exaggerated cytokine response aggravating lung injury

General anatomy report of novel coronavirus pneumonia death corpse

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Initiating acute dialysis at earlier Acute Kidney Injury Network stage in critically ill patients without traditional indications does not improve outcome: a prospective cohort study

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine

Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

RNA sequencing by direct tagmentation of RNA/DNA hybrids

COVID-19 Drug Therapy

Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Pillai SK; Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States

Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro

Antiviral effects of Glycyrrhiza species

The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb

Homeopathic treatment of patients with influenza-like illness during the 2009 A/H1N1 influenza pandemic in India

Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review

Intravenous immunoglobulin as clinical immune-modulating therapy

Anti-SARS coronavirus agents: a patent review

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection

Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease Is Suspected. Interim Guidance

Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)

Rolling updates on coronavirus disease (COVID-19)

Venice carnival closes as Italy imposes lockdown

Trump extends US social distancing until April 30: live updates

To beat COVID-19, social distancing is a must

The health impact of residential retreats: a systematic review

Hospital beds (per 1,000 people)

Stability of SARS-CoV-2 in different environmental conditions

India is enforcing the harshest and most extensive COVID-19 Lockdown in the world

Lack of compassion, more than resources, marks india's deadly lockdown mismanagement

Coronavirus: WHO lauds Modi government's social outreach during lockdown

Lockdown in India was early, far-sighted and courageous': WHO envoy

An environmental and health perspective for COVID-19 outbreak: Meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations

Association between ambient temperature and COVID-19 infection in 122 cities from China

Effects of temperature variation and humidity on the death of COVID-19 in Wuhan

Correlation between weather and Covid-19 pandemic in Jakarta

Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?

Air pollution

Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID

Effect of restricted emissions during COVID-19 on air quality in India

Indirect effects of COVID-19 on the environment

Changes in air quality during the lockdown in Barcelona (Spain) one month into the SARS-CoV-2 epidemic

Estimation of COVID-19 prevalence in Italy

Modeling containing covid-19 infection. A conceptual model

Effect of lockdown amid COVID-19 pandemic on air quality of the megacity Delhi

Assessing nitrogen dioxide (NO 2 ) levels as a contributing factor to coronavirus (COVID-19) fatality

Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil

Does environmental noise affect housing rental prices in developing countries?

The economic value of natural protected areas in Ecuador: a case of Villamil Beach National Recreation Area

Food waste matters-a systematic review of household food waste practices and their policy implications

The COVID-19 pandemic is generating tons of medical waste

Waste paper recycling decision system based on material flow analysis and life cycle assessment: A case study of waste paper recycling from China

Recycle more, waste more?

Single-use items not safest option amid COVID-19

Water, sanitation, hygiene, and waste management for COVID-19

False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence

Are SARS-CoV-2 reinfection and Covid-19 recurrence possible?

Characteristics of COVID-19 recurrence: a systematic review and meta-analysis

Available from: medRxiv

Recurrence of COVID-19 after recovery: a case report from Italy

The authors would like to thank the Department of Environmental Science of Sukanta Mahavidyalaya and The University of Burdwan for allowing working from home during the lockdown period.